Author
Listed:
- Jong-Ho Lee
(The University of Texas MD Anderson Cancer Center)
- Rui Liu
(The University of Texas MD Anderson Cancer Center
Sichuan University)
- Jing Li
(The University of Texas MD Anderson Cancer Center
Sichuan University)
- Chuanbao Zhang
(Capital Medical University)
- Yugang Wang
(The University of Texas MD Anderson Cancer Center)
- Qingsong Cai
(The University of Texas MD Anderson Cancer Center)
- Xu Qian
(The University of Texas MD Anderson Cancer Center)
- Yan Xia
(The University of Texas MD Anderson Cancer Center)
- Yanhua Zheng
(The University of Texas MD Anderson Cancer Center)
- Yuji Piao
(The University of Texas MD Anderson Cancer Center)
- Qianming Chen
(Sichuan University)
- John F. Groot
(The University of Texas MD Anderson Cancer Center)
- Tao Jiang
(Capital Medical University)
- Zhimin Lu
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas Graduate School of Biomedical Sciences at Houston)
Abstract
Phosphofructokinase 1 (PFK1) plays a critical role in glycolysis; however, its role and regulation in tumorigenesis are not well understood. Here, we demonstrate that PFK1 platelet isoform (PFKP) is the predominant PFK1 isoform in human glioblastoma cells and its expression correlates with total PFK activity. We show that PFKP is overexpressed in human glioblastoma specimens due to an increased stability, which is induced by AKT activation resulting from phosphatase and tensin homologue (PTEN) loss and EGFR-dependent PI3K activation. AKT binds to and phosphorylates PFKP at S386, and this phosphorylation inhibits the binding of TRIM21 E3 ligase to PFKP and the subsequent TRIM21-mediated polyubiquitylation and degradation of PFKP. PFKP S386 phosphorylation increases PFKP expression and promotes aerobic glycolysis, cell proliferation, and brain tumor growth. In addition, S386 phosphorylation in human glioblastoma specimens positively correlates with PFKP expression, AKT S473 phosphorylation, and poor prognosis. These findings underscore the potential role and regulation of PFKP in human glioblastoma development.
Suggested Citation
Jong-Ho Lee & Rui Liu & Jing Li & Chuanbao Zhang & Yugang Wang & Qingsong Cai & Xu Qian & Yan Xia & Yanhua Zheng & Yuji Piao & Qianming Chen & John F. Groot & Tao Jiang & Zhimin Lu, 2017.
"Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis,"
Nature Communications, Nature, vol. 8(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00906-9
DOI: 10.1038/s41467-017-00906-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00906-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.